A $3 billion China investment targets localized oral solid-dose manufacturing and supply-chain redundancy to support ...
SteinCares and Shilpa Biologicals have entered a licensing agreement to commercialize biosimilars in Latin America. Under the deal, SteinCares will manage regional registration and distribution, while ...
Orphan drugs are forecast to surpass $400 billion in 2032 sales, driven by accelerating rare disease innovation despite regulatory volatility, pricing pressures, and capital competition from ...
Kroger’s retail rollout shifts Zepbound KwikPen distribution from direct-to-consumer to community pharmacy channels, potentially reducing friction in initiation and refills for GLP-1 obesity therapy.
In today’s Pharma Pulse, Antengene and UCB ink a $1.18 billion global deal for ATG-201 to target autoimmune diseases, while ...
Data provided by BackOps indicates significant performance gains for early adopters across various industries, including retail, grocery, and manufacturing. The platform reportedly accelerates ...
In a recent interview, Jay Bregman, founder and CEO of Andel, discussed his company's newly launched direct-to-employer medication platform, which is designed to reduce prescription drug costs by ...
In today’s Pharma Pulse, the FDA launched a unified monitoring system to enable real-time adverse event reporting, and direct-to-employer drug purchasing models are emerging as companies look to ...
Agreement enables Hims & Hers users to access branded Ozempic 0.5–2 mg and Wegovy injectable 0.25–2.4 mg plus oral strengths 1.5–25 mg. Hims & Hers will cease marketing compounded GLP-1 products and ...
SpotSee and Controlant announced a collaboration to enhance pharmaceutical supply chain visibility using integrated ...
Decision intelligence helps pharma unify small molecule and cell and gene therapy supply chains through AI-driven, automated decision-making.
In today's Pharma Pulse, Ipsen voluntarily withdraws tazemetostat due to safety signals, while the FDA approves deucravacitinib for active psoriatic arthritis. That's it for this episode of Pharma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results